Cargando…
Development of synthetic lethality in cancer: molecular and cellular classification
Recently, genetically targeted cancer therapies have been a topic of great interest. Synthetic lethality provides a new approach for the treatment of mutated genes that were previously considered unable to be targeted in traditional genotype-targeted treatments. The increasing researches and applica...
Autores principales: | Li, Shijie, Topatana, Win, Juengpanich, Sarun, Cao, Jiasheng, Hu, Jiahao, Zhang, Bin, Ma, Diana, Cai, Xiujun, Chen, Mingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573576/ https://www.ncbi.nlm.nih.gov/pubmed/33077733 http://dx.doi.org/10.1038/s41392-020-00358-6 |
Ejemplares similares
-
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
por: Topatana, Win, et al.
Publicado: (2020) -
Targeting mutant p53 for cancer therapy: direct and indirect strategies
por: Hu, Jiahao, et al.
Publicado: (2021) -
Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer
por: Cao, Jiasheng, et al.
Publicado: (2021) -
Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery
por: Chen, Mingyu, et al.
Publicado: (2021) -
Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning
por: Chen, Mingyu, et al.
Publicado: (2020)